Scarica l'app Stockscreener
1.55
9.15%
0.13
Pre-mercato:
1.55
Precedente Chiudi:
$1.42
Aprire:
$1.48
Volume 24 ore:
377.17K
Relative Volume:
0.09
Capitalizzazione di mercato:
$3.83M
Reddito:
$1.35M
Utile/perdita netta:
$-7.97M
Rapporto P/E:
-0.063
EPS:
-24.6063
Flusso di cassa netto:
$-6.88M
1 W Prestazione:
-26.89%
1M Prestazione:
-49.51%
6M Prestazione:
-72.12%
1 anno Prestazione:
-79.50%
Intervallo 1D:
$1.44
$1.60
Intervallo di 1 settimana:
$1.29
$2.11
Portata 52W:
$1.29
$17.68
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.55 | 3.83M | 1.35M | -7.97M | -6.88M | -24.61 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
Published on: 2026-03-26 13:08:49 - baoquankhu1.vn
Gap Down: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 Geopolitical Influence & Verified Trade Idea Suggestions - baoquankhu1.vn
Signal Recap: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
If You Invested $1,000 in 60 degrees pharmaceuticals, Inc. (SXTP) - Stock Titan
Performance Recap: Is 60 Degrees Pharmaceuticals Inc a momentum stock2026 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
60 Degrees Updates Affiliate Share Ownership Disclosure Error - The Globe and Mail
Aug Levels: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Corrects Prospectus Supplement Disclosure in SEC Form 8-K Filing (March 20, 2026) - Minichart
60 Degrees Pharmaceuticals corrects affiliate share counts in prospectus supplement - TradingView
Affiliate share ownership restated by 60 Degrees (NASDAQ: SXTP) - Stock Titan
Death Cross: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sector2026 Key Highlights & AI Powered Market Entry Ideas - baoquankhu1.vn
60 Degrees Pharma submits dietary supplement notification to FDA By Investing.com - Investing.com Australia
Bull Run: Can 60 Degrees Pharmaceuticals Inc sustain earnings growth2026 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
60 Degrees submits NDIN to FDA for Australian Chestnut Extract - TipRanks
60 Degrees Pharma submits dietary supplement notification to FDA - Investing.com
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract - TradingView
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - The Manila Times
Gains Report: Can 60 Degrees Pharmaceuticals Inc be recession proofInsider Buying & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Market Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sectorMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Volatility Watch: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2026 Valuation Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
60 Degrees Pharmaceuticals files updated legal opinion for at-the-market offering - Investing.com Nigeria
What's going on with 60 Degrees Pharmaceuticals on Friday? - MSN
60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion for ATM Equity Offering Program – March 2026 - Minichart
60 Degrees Pharmaceuticals files updated legal opinion for ATM equity program - Investing.com Australia
60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity - TradingView
60 Degrees Pharmaceuticals Updates Opinion for ATM Program - The Globe and Mail
60 Degrees (SXTP) updates ATM capacity to $565K after prior sales - Stock Titan
60 Degrees Pharmaceuticals (SXTP) updates legal opinion for at-the-market stock program - Stock Titan
What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
Quarterly Risk: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Files Form 8-K With NASDAQ Listing Details and Corporate Information - Minichart
60 Degrees Pharmaceuticals (NASDAQ: SXTP) updates legal opinion for ATM equity program - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
60 Degrees Pharma flies after curing tick disease in small-scale study - Mugglehead Investment Magazine
60 Degrees reports babesiosis cure in three trial patients - Investing.com India
60 Degrees reports babesiosis cure in three trial patients By Investing.com - Investing.com Canada
[424B5] 60 DEGREES PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
SXTP Stock Dips Amid Earnings Shake: Investors On Edge - timothysykes.com
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial - The Manila Times
60 Degrees Pharmaceuticals Announces All Patients Cured of - GlobeNewswire
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Big Picture: What are analysts price targets for 60 Degrees Pharmaceuticals Inc Equity WarrantJuly 2025 Snapshot & Long-Term Capital Growth Ideas - baoquankhu1.vn
How interest rate cuts could boost 60 Degrees Pharmaceuticals Inc. stockTake Profit & AI Enhanced Execution Alerts - Naître et grandir
Earnings Update: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2025 Sector Review & Risk Managed Investment Strategies - baoquankhu1.vn
Top 2seventy bio (ZTWO) Competitors 2026 - MarketBeat
Short Squeeze: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2025 Geopolitical Influence & AI Forecasted Stock Moves - baoquankhu1.vn
SXTP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SXTPW SEC Filings60 Degrees Pharm 10-K, 10-Q, 8-K Forms - Stock Titan
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):